MANNKIND CORP Debt Conversion, Original Debt, Amount
MANNKIND CORP (MNKD) reported Debt Conversion, Original Debt, Amount of $93.50 million for the 12-month period ending 2014-12-31, per its 10-K filed 2017-03-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2017-03-16
- MANNKIND CORP debt conversion, original debt, amount for the quarter ending 2014-12-31 was $0.00.
- MANNKIND CORP debt conversion, original debt, amount for the quarter ending 2014-09-30 was $0.00.
- MANNKIND CORP debt conversion, original debt, amount for the quarter ending 2014-06-30 was $7.50M.
- MANNKIND CORP debt conversion, original debt, amount for the quarter ending 2014-03-31 was $86.00M.
- MANNKIND CORP debt conversion, original debt, amount for fiscal 2014 was $93.50M, a 1338.46% increase from fiscal 2013.
- MANNKIND CORP debt conversion, original debt, amount for fiscal 2013 was $6.50M.
| Period end | Debt Conversion, Original Debt, Amount 3 month | Debt Conversion, Original Debt, Amount 6 month | Debt Conversion, Original Debt, Amount 9 month | Debt Conversion, Original Debt, Amount 12 month | Debt Conversion, Original Debt, Amount 275 month | Debt Conversion, Original Debt, Amount 277 month | Debt Conversion, Original Debt, Amount 280 month | Debt Conversion, Original Debt, Amount 283 month |
|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $0.00 derived: sum of 2 quarters · filed 2017-03-16 | $7.50M derived: sum of 3 quarters · filed 2017-03-16 | $93.50M 10-K · filed 2017-03-16 | ||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $7.50M derived: sum of 2 quarters · filed 2015-11-09 | $93.50M 10-Q · filed 2015-11-09 | $100.00M 10-Q · filed 2014-11-10 | ||||
| 2014-06-30 | $7.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $93.50M 10-Q · filed 2015-08-10 | $100.00M 10-Q · filed 2014-08-11 | |||||
| 2014-03-31 | $86.00M 10-Q · filed 2014-05-12 | $92.50M 10-Q · filed 2014-05-12 | ||||||
| 2013-12-31 | $6.50M 10-K · filed 2016-03-15 | $6.50M 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |